149 related articles for article (PubMed ID: 25318053)
21. Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
Reason D; Liberato J; Sun J; Camacho J; Zhou J
Toxins (Basel); 2011 Aug; 3(8):979-90. PubMed ID: 22069752
[TBL] [Abstract][Full Text] [Related]
22. Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane-penetrating loop.
Hoelzgen F; Zalk R; Alcalay R; Cohen-Schwartz S; Garau G; Shahar A; Mazor O; Frank GA
Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1197-1205. PubMed ID: 34473089
[TBL] [Abstract][Full Text] [Related]
23. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
24. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.
Mohamed N; Li J; Ferreira CS; Little SF; Friedlander AM; Spitalny GL; Casey LS
Infect Immun; 2004 Jun; 72(6):3276-83. PubMed ID: 15155630
[TBL] [Abstract][Full Text] [Related]
26. Rapid Discovery and Characterization of Synthetic Neutralizing Antibodies against Anthrax Edema Toxin.
Farcasanu M; Wang AG; Uchański T; Bailey LJ; Yue J; Chen Z; Wu X; Kossiakoff A; Tang WJ
Biochemistry; 2019 Jul; 58(27):2996-3004. PubMed ID: 31243996
[TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
[TBL] [Abstract][Full Text] [Related]
28. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
[TBL] [Abstract][Full Text] [Related]
29. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
30. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
[TBL] [Abstract][Full Text] [Related]
31. Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
Verma A; Ngundi MM; Price GA; Takeda K; Yu J; Burns DL
mBio; 2018 Feb; 9(1):. PubMed ID: 29487236
[TBL] [Abstract][Full Text] [Related]
32. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
[TBL] [Abstract][Full Text] [Related]
33. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
[TBL] [Abstract][Full Text] [Related]
34. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
[TBL] [Abstract][Full Text] [Related]
35. Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model.
Makam SS; Kingston JJ; Harischandra MS; Batra HV
Mol Immunol; 2014 May; 59(1):91-9. PubMed ID: 24513572
[TBL] [Abstract][Full Text] [Related]
36. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
[TBL] [Abstract][Full Text] [Related]
37. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
Huang B; Xie T; Rotstein D; Fang H; Frucht DM
Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
[TBL] [Abstract][Full Text] [Related]
38. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
[TBL] [Abstract][Full Text] [Related]
39. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
Maynard JA; Maassen CB; Leppla SH; Brasky K; Patterson JL; Iverson BL; Georgiou G
Nat Biotechnol; 2002 Jun; 20(6):597-601. PubMed ID: 12042864
[TBL] [Abstract][Full Text] [Related]
40. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.
Hull AK; Criscuolo CJ; Mett V; Groen H; Steeman W; Westra H; Chapman G; Legutki B; Baillie L; Yusibov V
Vaccine; 2005 Mar; 23(17-18):2082-6. PubMed ID: 15755575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]